Investing.com - Kalvista Pharma reported on Thursday first quarter earnings that beat analysts' forecasts and revenue that was inline with expectations.
Kalvista Pharma announced earnings per share of $-0.94 on revenue of $0.00. Analysts polled by Investing.com anticipated EPS of $-1.04 on revenue of $0.00.
Kalvista Pharma shares are up 20% from the beginning of the year , still down 26.86% from its 52 week high of $21.76 set on Friday, September 10, 2021. They are outperforming the Nasdaq which is down 24.49% year to date.
Kalvista Pharma shares gained 1.73% in intra-day trade the report.
Kalvista Pharma follows other major Healthcare sector earnings this month
Kalvista Pharma's report follows an earnings beat by Medtronic on Tuesday, August 23, 2022, who reported EPS of $1.13 on revenue of $7.37B, compared to forecasts EPS of $1.12 on revenue of $7.22B.
Agilent Technologies had beat expectations on Tuesday, August 16, 2022 with third quarter EPS of $1.34 on revenue of $1.72B, compared to forecast for EPS of $1.2 on revenue of $1.64B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar